AnalystsOren LivnatOren Livnat's Stock Forecasts
AnalystsOren Livnat
Analyst Ranking
Top 7%
#354 out of 5116 analysts
Average Return
+13.07%
Win Rate
50%86 out of 173
Risk vs Reward
Poor
Good
Oren Livnat's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avadel Pharmaceuticals PLCAVDL | +453.60% | $2.50 | $13.84 | 2022-05-27 - 2023-05-26 | Buy |
Trevi Therapeutics IncTRVI | +266.39% | $3.60 | $13.19 | 2024-12-12 - 2025-11-28 | Buy |
Trevi Therapeutics IncTRVI | +229.72% | $3.23 | $10.65 | 2024-10-22 - 2025-10-21 | Buy |
Trevi Therapeutics IncTRVI | +216.31% | $4.17 | $13.19 | 2024-12-13 - 2025-11-28 | Buy |
Tarsus Pharmaceuticals IncTARS | +182.88% | $17.47 | $49.42 | 2023-11-10 - 2024-11-08 | Buy |
Oren Livnat Analyst Color
Get additional color on Oren Livnat's coverage of popular stocks
Oren Livnat's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pacira Biosciences IncPCRX | 19 | Buy | $65.00 | +175.77% | Maintains | 8 months ago |
Collegium Pharmaceutical IncCOLL | 7 | Buy | $50.00 | +7.11% | Reiterates | 8 months ago |
Trevi Therapeutics IncTRVI | 6 | Buy | $12.50 | -5.23% | Reiterates | 8 months ago |
Ani Pharmaceuticals IncANIP | 13 | Buy | $94.00 | +10.78% | Reiterates | 8 months ago |
Zevra Therapeutics IncZVRA | 12 | Buy | $20.00 | +132.56% | Reiterates | 9 months ago |
Jazz Pharmaceuticals PLCJAZZ | 16 | Buy | $217.00 | +22.93% | Maintains | 9 months ago |
Xeris Biopharma Holdings IncXERS | 11 | Buy | $8.00 | +11.42% | Reiterates | 9 months ago |
Avadel Pharmaceuticals PLCAVDL | 16 | Buy | $21.00 | -2.28% | Reiterates | 9 months ago |
Tarsus Pharmaceuticals IncTARS | 9 | Buy | $73.00 | -8.70% | Reiterates | 9 months ago |
Grace Therapeutics IncGRCE | 3 | Buy | $12.00 | +277.36% | Reiterates | 9 months ago |
Tvardi Therapeutics IncTVRD | 11 | Buy | $43.20 | N/A | Reiterates | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 10 | Buy | $140.00 | N/A | Maintains | 2 years ago |
Mannkind CorpMNKD | 6 | Buy | $7.50 | N/A | Reiterates | 2 years ago |
Agile Therapeutics IncAGRX | 9 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Satsuma Pharmaceuticals IncSTSA | 4 | Buy | $3.00 | N/A | Reiterates | 3 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Novan IncNOVNQ | 6 | Buy | $17.00 | N/A | Maintains | 3 years ago |
Otonomy IncOTIC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Scynexis IncSCYX | 2 | Buy | $8.00 | N/A | Maintains | 4 years ago |
Antares Pharma IncATRS | 3 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Biodelivery Sciences International IncBDSI | 5 | Hold | $4.50 | N/A | Maintains | 4 years ago |
Lipocine IncLPCN | 5 | Buy | $59.50 | N/A | Maintains | 4 years ago |
Taiwan Liposome Company LtdTLC | 2 | Hold | $7.50 | N/A | Downgrades | 4 years ago |
Vyne Therapeutics IncVYNE | 2 | Buy | $198.00 | N/A | Maintains | 5 years ago |
Corium International IncCORI | 2 | Hold | $13.00 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.